Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 147-94-4 | Product Number: C2035
Cytarabine
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
- Arabinocytidine
- Cytosine β-D-Arabinofuranoside
- Ara-C
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 1G |
€32.00
|
Contact Us | ≥100 |
|
| 5G |
€102.00
|
7 | 38 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | C2035 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__9H__1__3N__3O__5 = 243.22 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 147-94-4 |
| Related CAS RN | 69-74-9 |
| Reaxys Registry Number | 89175 |
| PubChem Substance ID | 87558791 |
| Merck Index (14) | 2784 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +155.0 to +162.0 deg(C=1, H2O) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 214 °C |
| Specific Rotation | 158° (C=1,H2O) |
| Maximum Absorption Wavelength | 272(H2O) nm |
| Solubility in water | Soluble |
GHS
Related Laws:
| EC Number | 205-705-9 |
| RTECS# | HA5425000 |
Transport Information:
| HS Number | 2934999090 |
Application
Cytarabine (ara-C): D-Arabinosyl Nucleoside exhibiting Anti-Leukemia and Anti-DNA Virus Activities
Certain D-arabinosyl nucleosides, notably cytarabine (ara-C) and vidarabine (ara-A) [V0098] are used as an anti-leukemia agent and an anti-DNA virus agent. Ara-C and ara-A are cell cycle phase-specific antineoplastic agents, affecting cells only during the S-phase of cell division. Intracellularly, ara-C and ara-A are converted into the 5-triphosphates (ara-CTP and ara-ATP), which are the active metabolites. The mechanism of actions are not completely understood, but it appear that ara-CTP and ara-ATP act through the inhibition of tumor cell or virus-induced DNA polymerases, competing with dCTP and dATP, respectively. Incorporation of them into DNA and RNA also contribute to their cytotoxicity. (The product is for research purpose only.)
References
- The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA) (a review)
- Ara-C: cellular and molecular pharmacology (a review)
- Acute Myeloid Leukemia (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.